{
    "answer": "For Q4 2024, Cosentyx's immunology segment net sales were USD 1.7 billion, an increase of +27% (reported) and +26% (constant currency) compared to the 2023 period (data not fully available).",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 3,
    "search count": 2,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        962,
        2429,
        3985
    ]
}